CBiPES hydrochloride
SIGMA/C9749 - ≥98% (HPLC)
Synonym: N-(4′-cyano[1,1′-biphenyl]-3-yl)-N-(3-pyridinylmethyl)-ethanesulfonamide hydrochloride
CAS Number: 856702-40-4
Empirical Formula (Hill Notation): C21H19N3O2S · HCl
Molecular Weight: 413.92
MDL Number: MFCD18086913
Linear Formula: C21H19N3O2S · HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | off-white to light brown |
| form | powder |
| InChI | 1S/C21H19N3O2S.ClH/c1-2-2 |
| InChI key | QKUHSVQWWZBAKM-UHFFFAOYSA |
| originator | Eli Lilly |
| Quality Level | 100 ![]() |
| SMILES string | [S](=O)(=O)(N(Cc3cnccc3)c |
| solubility | DMSO: >20 mg/mL |
| storage condition | desiccated |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | CBiPES is a positive allosteric modulator of the mGlu2 receptor. |
| Biochem/physiol Actions: | CBiPES is a positive allosteric modulator of the mGlu2 receptor. CBiPES attenuates stress-induced hyperthermia and blocks the hyperlocomotor effects of PCP in murine models. In rat brain, CBiPES attenuates ketamine-induced increase in extracellular histamine concentration. This compound is a sulfonamide, different chemical class from other mGlu2R agonists in the Sigma catalog. |
| Features and Benefits: | This compound is featured on the Glutamate Receptors (G Protein Family) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Eli Lilly . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

